These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. TFOS DEWS II Report Executive Summary. Craig JP; Nelson JD; Azar DT; Belmonte C; Bron AJ; Chauhan SK; de Paiva CS; Gomes JAP; Hammitt KM; Jones L; Nichols JJ; Nichols KK; Novack GD; Stapleton FJ; Willcox MDP; Wolffsohn JS; Sullivan DA Ocul Surf; 2017 Oct; 15(4):802-812. PubMed ID: 28797892 [TBL] [Abstract][Full Text] [Related]
16. TFOS DEWS II Management and Therapy Report. Jones L; Downie LE; Korb D; Benitez-Del-Castillo JM; Dana R; Deng SX; Dong PN; Geerling G; Hida RY; Liu Y; Seo KY; Tauber J; Wakamatsu TH; Xu J; Wolffsohn JS; Craig JP Ocul Surf; 2017 Jul; 15(3):575-628. PubMed ID: 28736343 [TBL] [Abstract][Full Text] [Related]
17. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification. Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of the Tear Meniscus Osmolarity Measurement for Dry Eye Disease in Rheumatoid Arthritis Patients. De La Parra-Colin P; Palacios-Aguirre K; Perez-Pria-Kasusky A; Espinosa-Morales R; Hidalgo-Bravo A Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761361 [TBL] [Abstract][Full Text] [Related]